The Power of Diversity in Pseudomonas Resistance
Resistant gram-negative pathogens with perpetually evolving mechanisms continue to cause millions of infections annually in the United States. Older adults with multiple comorbidities receiving polypharmacy and those who are frequently exposed to the healthcare system are especially vulnerable to infections caused by Pseudomonas aeruginosa. This dilemma presents unique challenges for senior care and consultant pharmacists who care for these patients. Throughout this presentation, clinicians will identify and interpret commonly occurring mechanisms of resistance and apply best clinical practices to optimize therapy for the older adult population.
Learning Objectives
At the conclusion of this application-based activity, participants should be able to:
- Describe recent epidemiological trends of infections caused by drug-resistant Pseudomonas aeruginosa
- Review the mechanisms of resistance of Pseudomonas aeruginosas
- Apply recent IDSA guidance to optimize therapy for infections caused by Pseudomonas aeruginosa with difficult-to-treat resistance
- Formulate an optimal antibiotic treatment plan for an older adult infected with Pseudomonas aeruginosa
Target Audience
Senior Care Pharmacists who provide expert advice on the use of medications to individuals and older adults and are committed to providing person-centered care, considering the complex interrelationships between disease states, nutrition, medications, and other variables.
Speaker
Elias B. Chahine PharmD, FCCP, FASCP, FFSHP, BCPS, BCIDP
Professor of Pharmacy Practice
Palm Beach Atlantic University Gregory School of Pharmacy
John Millard PharmD, BCPS, BCGP, BCIDP
Clinical Pharmacist Practitioner
Dole VA Medical Center
Financial Disclosure
Elias B. Chahine: Speakers’ bureau and advisory board of Seqirus
John W. Millard:
- Invested into workplace retirement funds with no control over individual assets allocation and as a result may directly own portions of the companies which products are herewith in discussed.
- Holds medical device and utility patents in diagnostic modalities regarding neurological and meningeal infectious etiology that are outside the scope of this presentation.
- The views expressed in this presentation reflect those of the presenter, and not those of the Department of Veteran Affairs.
- All relevant financial relationships have been mitigated.
How to Access Content
-
Select “launch” to open the course. Click through the menu items in sequence to move through the course process to claim credit. You must complete the course in its entirety to claim credit
-
Post-test be completed, with minimum score of 75%, before moving on to the evaluation.
-
All courses contain an evaluation that must be completed
-
Once you have completed the course evaluation, please confirm proper submission by checking your CPE Monitor/and or BPS portal (BCGP pharmacists) within 24-48 hours of course completion.
-
If you need assistance, email the Education Department at
education@ascp.com
Claim Credit
UAN: 0203-9999-24-013-H01-P
Date of Release: 03/01/2024
Date of Expiration: 03/01/2025 11:59pm ET
BCGP Pharmacists: To ensure successful transfer of BCGP credit, your ASCP profile must be updated with your correct BCGP Credential Number and BPS-IND# prior to course completion. *Please note, any edit/updates made to your BCGP credential information in your ASCP profile after course completion requires a re-push, please submit your completed transcript to education@ascp.com for a manual upload.
CPE & BCGP Credit: You must complete the post-test and evaluation by the expiration date to receive credit. You have three attempts to achieve a 75% or higher on the post-test. ASCP reports CPE attainment to ACPE and NABP via the CPE Monitor system. The course should be posted within 24-48 hours of evaluation completion. It is the responsibility of the participant to provide their correct date of birth (MMDD format) and NABP e-Profile ID on their member or guest profile on the ASCP Website.
This educational activity was developed by the American Society of Consulting Pharmacists (ASCP) in collaboration with the American Pharmacists Association (APhA). To study a case about this topic through APhA, please visit the catalog to learn more. ASCP members will receive the APhA member rate when using this code: ASCPMBR
Accreditation
ASCP is approved by BPS as a provider for the recertification of BCGP.
The American Society of Consultant Pharmacists (ASCP) is accredited by
the Accreditation Council for Pharmacy Education (ACPE) as a provider
of continuing pharmacy education.